National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-CS1 monoclonal antibody HuLuc63
A humanized monoclonal antibody directed against the human CS1 (CD2 subset 1, CRACC, SLAMF7) antigen with potential antineoplastic activity. Anti-CS1 monoclonal antibody HuLuc63 binds to the CS1 antigen, which may trigger antibody-dependent cellular cytotoxicity (ADCC) in cells expressing CS1. CS1 is a cell surface glycoprotein belonging to the CD2 subset of the immunoglobulin superfamily (IgSF) and is highly expressed by multiple myeloma cells, but minimally expressed by normal cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:HuLuc63



Previous:anti-CD45 monoclonal antibody, anti-CD45 monoclonal antibody AHN-12, anti-CD70 monoclonal antibody MDX-1411, anti-CEA IgCD28TCR-transduced autologous T cells, anti-CEA/anti-DTPA-In (F6-734) bispecific antibody
Next:anti-denatured collagen recombinant monoclonal antibody TRC093, anti-DR5 agonist monoclonal antibody TRA-8, anti-EGFR monoclonal antibody RO5083945, anti-EGFRvIII vaccine CDX-110, anti-endoglin monoclonal antibody TRC105

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov